{"id":8365,"date":"2016-07-28T12:02:04","date_gmt":"2016-07-28T12:02:04","guid":{"rendered":"\/articles\/?p=8365"},"modified":"2016-07-28T12:14:37","modified_gmt":"2016-07-28T12:14:37","slug":"oxis-international-inc-otcmktsoxis-crashes-in-spite-of-news","status":"publish","type":"post","link":"\/articles\/oxis-international-inc-otcmktsoxis-crashes-in-spite-of-news\/","title":{"rendered":"OXIS International, Inc. (OTCMKTS:OXIS) Crashes In Spite Of News"},"content":{"rendered":"<p>tags: OXIS <\/p>\n<p><img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/94\/94005\/sc.png\" border=\"0\" width=\"429\" height=\"191\" \/><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=OXIS\">OXIS<\/a> International, Inc. (OTCMKTS:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=OXIS\">OXIS<\/a>) lost its footing once more yesterday, in spite of publishing an optimistic PR just the day before. What is up with that? <\/p>\n<p>By all accounts, the news that the company had teamed up with the University of Minnesota to develop and commercialize cancer therapies using Trispecific Killer Engager should have afforded <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=OXIS\">OXIS<\/a> <\/strong>some more leeway. Obviously, that didn&rsquo;t happen &ndash; in fact, quite the opposite is true, which is somewhat confusing.<\/p>\n<p>Or, to be precise, it would be confusing, if you didn&rsquo;t take into account some of the other circumstances surrounding the company.<\/p>\n<p>As we have mentioned on occasion in the past, the company&rsquo;s latest financial report wasn&rsquo;t inspiring at all:<\/p>\n<ul>\n<li>Cash and cash equivalents &#8211; $30 thousand<\/li>\n<li>Total Current Assets &#8211; $32 thousand<\/li>\n<li>Total Current Liabilities &#8211; $19 MILLION<\/li>\n<li>Net cash used in operating activities during the last reported quarter &#8211; $167 thousand<\/li>\n<\/ul>\n<p>It doesn&rsquo;t take a financial expert to see the discrepancy here. <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=OXIS\">OXIS<\/a> <\/strong>claims to be involved in serious cancer research. How is it managing that while at the same time spending less than $170 thousand per quarter?<\/p>\n<p>The company&#8217;s assets don&rsquo;t inspire confidence, either. True enough, <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=OXIS\">OXIS<\/a> <\/strong>did acquire $585 thousand worth of funding by selling 1.7 million shares of its common stock a while back &ndash; but how long will that last?<\/p>\n<p>One silver lining to be found here is that after the last two steps down, said shares can no longer be sold at a profit. However, make no mistake &ndash; even though it has gone inert for now, the threat they represent for investor value is not to be underestimated. What&#8217;s more, and it&rsquo;s not like this is the only red flag that researching&nbsp;<strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=OXIS\">OXIS<\/a>&#8216;s<\/strong> flings can reveal.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" style=\"float: left;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/94\/94005\/vzxcvxzcv.jpg\" border=\"0\" width=\"116\" height=\"29\" \/>With this in mind, it should be quite obvious why the ticker is falling.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>tags: OXIS OXIS International, Inc. (OTCMKTS:OXIS) lost its footing once more yesterday, in spite of publishing an optimistic PR just the day before. What is up with that? By all accounts, the news that&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8365","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/8365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=8365"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/8365\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=8365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=8365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=8365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}